Immunofoco is a global pioneer advancing ex vivo CAR-T therapies for solid tumors and in vivo CAR-T therapies across multiple disease areas, establishing a powerful “dual-engine” growth model.
| Website | https://www.immunofoco.com/ |
| Employees | 5 (2 on RocketReach) |
| Founded | 2020 |
| Phone | +86 21 5090 7211 |
| Industry | Biotechnology Research |
Looking for a particular Immunofoco employee's phone or email?
2 people are employed at Immunofoco.